• Xuelan Huang, Suwen Bai, and Yumei Luo.
• Guangdong Medical University, Zhanjiang, China.
• Medicine (Baltimore). 2024 Apr 12; 103 (15): e37793e37793.

AbstractAcute myocardial infarction (AMI), the most severe cardiovascular event in clinical settings, imposes a significant burden with its annual increase in morbidity and mortality rates. However, it is noteworthy that mortality due to AMI in developed countries has experienced a decline, largely attributable to the advancements in medical interventions such as percutaneous coronary intervention. This trend highlights the importance of accurate diagnosis and effective treatment to preserve the myocardium at risk and improve patient outcomes. Conventional biomarkers such as myoglobin, creatine kinase isoenzymes, and troponin have been instrumental in the diagnosis of AMI. However, recent years have witnessed the emergence of new biomarkers demonstrating the potential to further enhance the accuracy of AMI diagnosis. This literature review focuses on the recent advancements in biomarker research in the context of AMI diagnosis.Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

7 keywords...

hide…